206 related articles for article (PubMed ID: 20638026)
21. Chronic hepatitis B virus infection.
McMahon BJ
Med Clin North Am; 2014 Jan; 98(1):39-54. PubMed ID: 24266913
[TBL] [Abstract][Full Text] [Related]
22. Natural history and prognosis of hepatitis B.
Fattovich G
Semin Liver Dis; 2003 Feb; 23(1):47-58. PubMed ID: 12616450
[TBL] [Abstract][Full Text] [Related]
23. Why do I treat HBeAg-negative chronic hepatitis B patients with nucleos(t)ide analogues?
Papatheodoridis GV
Liver Int; 2013 Feb; 33 Suppl 1():151-6. PubMed ID: 23286859
[TBL] [Abstract][Full Text] [Related]
24. Long-term follow-up of interferon alfa treatment in Chinese patients with chronic hepatitis B infection: The effect on hepatitis B e antigen seroconversion and the development of cirrhosis-related complications.
Yuen MF; Hui CK; Cheng CC; Wu CH; Lai YP; Lai CL
Hepatology; 2001 Jul; 34(1):139-45. PubMed ID: 11431745
[TBL] [Abstract][Full Text] [Related]
25. [A report from the Chinese National Fourteenth Symposium on Viral Hepatitis and Liver Diseases].
Zhu HM; Zhang DZ
Zhonghua Gan Zang Bing Za Zhi; 2009 Aug; 17(8):636-7. PubMed ID: 19719931
[No Abstract] [Full Text] [Related]
26. Long-term lamivudine therapy reduces the risk of long-term complications of chronic hepatitis B infection even in patients without advanced disease.
Yuen MF; Seto WK; Chow DH; Tsui K; Wong DK; Ngai VW; Wong BC; Fung J; Yuen JC; Lai CL
Antivir Ther; 2007; 12(8):1295-303. PubMed ID: 18240869
[TBL] [Abstract][Full Text] [Related]
27. A proposed, evidence-based approach to the treatment of chronic Hepatitis B.
Han SH; Durazo FA; Saab S; Tong MJ
J Clin Gastroenterol; 2011 Mar; 45(3):259-66. PubMed ID: 20856136
[TBL] [Abstract][Full Text] [Related]
28. Tenofovir-best hope for treatment of chronic hepatitis B infection?
Örmeci N; Özbaş B; Güner R; Özkan H; Yalçı A; Çoban Ş; Dökmeci A; Kalkan Ç; Akıncı H; Yüksel O; Başar Ö; Yüksel İ; Balık İ
Turk J Gastroenterol; 2015 Jul; 26(4):322-7. PubMed ID: 26038999
[TBL] [Abstract][Full Text] [Related]
29. Treatment of chronic hepatitis B.
Cornberg M; Jaroszewicz J; Manns MP; Wedemeyer H
Minerva Gastroenterol Dietol; 2010 Dec; 56(4):451-65. PubMed ID: 21139543
[TBL] [Abstract][Full Text] [Related]
30. What can we learn from hepatitis B virus clinical cohorts?
Lin CL; Tseng TC; Kao JH
Liver Int; 2015 Jan; 35 Suppl 1():91-9. PubMed ID: 25529093
[TBL] [Abstract][Full Text] [Related]
31. Natural history of chronic hepatitis B.
McMahon BJ
Clin Liver Dis; 2010 Aug; 14(3):381-96. PubMed ID: 20638020
[TBL] [Abstract][Full Text] [Related]
32. Impact of etiological treatment on prognosis.
Su CW; Yang YY; Lin HC
Hepatol Int; 2018 Feb; 12(Suppl 1):56-67. PubMed ID: 28702738
[TBL] [Abstract][Full Text] [Related]
33. [Chronic hepatitis B: current therapy].
Buffet C
Bull Acad Natl Med; 2008 Nov; 192(8):1625-37; discussion 1638-9. PubMed ID: 19445377
[TBL] [Abstract][Full Text] [Related]
34. Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study.
Papatheodoridis GV; Manolakopoulos S; Touloumi G; Vourli G; Raptopoulou-Gigi M; Vafiadis-Zoumbouli I; Vasiliadis T; Mimidis K; Gogos C; Ketikoglou I; Manesis EK;
Gut; 2011 Aug; 60(8):1109-16. PubMed ID: 21270118
[TBL] [Abstract][Full Text] [Related]
35. Why do I treat HBeAg-positive chronic hepatitis B patients with a nucleoside analogue.
Ma H; Jia J
Liver Int; 2013 Feb; 33 Suppl 1():133-6. PubMed ID: 23286857
[TBL] [Abstract][Full Text] [Related]
36. Clinical Relevance of HLA Gene Variants in HBV Infection.
Wang L; Zou ZQ; Wang K
J Immunol Res; 2016; 2016():9069375. PubMed ID: 27243039
[TBL] [Abstract][Full Text] [Related]
37. Treatment of chronic hepatitis B.
Yuen MF; Lai CL
Lancet Infect Dis; 2001 Nov; 1(4):232-41. PubMed ID: 11871510
[TBL] [Abstract][Full Text] [Related]
38. Clinical improvement in patients with decompensated liver disease caused by hepatitis B after treatment with lamivudine.
Sponseller CA; Bacon BR; Di Bisceglie AM
Liver Transpl; 2000 Nov; 6(6):715-20. PubMed ID: 11084057
[TBL] [Abstract][Full Text] [Related]
39. Risk assessment for the development of hepatocellular carcinoma: according to on-treatment viral response during long-term lamivudine therapy in hepatitis B virus-related liver disease.
Eun JR; Lee HJ; Kim TN; Lee KS
J Hepatol; 2010 Jul; 53(1):118-25. PubMed ID: 20471129
[TBL] [Abstract][Full Text] [Related]
40. Influence of hepatitis B virus reactivation on the recurrence of HBV-related hepatocellular carcinoma after curative resection in patients with low viral load.
Sohn W; Paik YH; Cho JY; Ahn JM; Choi GS; Kim JM; Kwon CH; Joh JW; Sinn DH; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
J Viral Hepat; 2015 Jun; 22(6):539-50. PubMed ID: 25377516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
